Is Cerebrolysin FDA approved?
No. This profile records Cerebrolysin as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Healing CATEGORY
Cerebrolysin
THE BRAIN REBUILDER
Neurotrophic Peptide Blend
Cerebrolysin is a mix of brain-derived peptides and neurotrophic factors that support neuron survival, growth, and repair. It's often used for cognitive recovery after stroke or traumatic brain injury, and in neurodegenerative conditions.
Cerebrolysin
Cerebrolysin
Cerebrolysin
Cerebrolysin Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Cerebrolysin
What dose does The Peptide App Clinical Team recommend for Cerebrolysin?
Dose: 5-10 mL daily for 10-20 days (IM or IV).
MORE CONTEXT ›
Schedule: daily. Cycle: 10-21 days on, then 3-6 month break. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Cerebrolysin guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Neurotrophic Support
Contains BDNF, NGF and other growth factors that help neurons survive and grow
Synapse Builder
Promotes new connections between brain cells (synaptogenesis)
Neuroprotection
Protects neurons from damage caused by inflammation and oxidative stress
Neurotransmitter Balance
Improves balance of dopamine, acetylcholine, and other brain chemicals
Stroke recovery patients
People with Alzheimer's or vascular dementia
Those recovering from traumatic brain injury
Aging individuals concerned about brain health
Cerebrolysin Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES